Edition:
India

Profile: Celon Pharma SA (CLNP.WA)

CLNP.WA on Warsaw Stock Exchange

37.40PLN
20 Oct 2020
Change (% chg)

0.15zł (+0.40%)
Prev Close
37.25zł
Open
37.95zł
Day's High
38.15zł
Day's Low
36.80zł
Volume
11,343
Avg. Vol
25,788
52-wk High
50.40zł
52-wk Low
23.05zł

Celon Pharma SA is a Poland-based company primarily engaged in the pharmaceuticals manufacture. The Company focuses on research, development and production of generic drugs for cancer, neurological diseases, diabetes and other metabolic disorders treatment, among others. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir and Valzek, as well as inhalation powder, such as Salmex. The Company's research center develops pharmaceuticals within a number of therapeutic areas, including oncology, neurology, as well as inflammatory and metabolic diseases. The Company is a subsidiary of Glatton sp z o o.

Company Address

Celon Pharma SA

ul. Ogrodowa 2A, Kielpin
    05-092
P: +4822.7515933
F: +4822.7514458

Company Web Links